Brief: Australian Clinical Labs Says It Intends To Withdraw Takeover Offer For Healius

Australian Clinical Labs

15/12/2023 01:02

Dec 15 (Reuters) - Australian Clinical Labs Ltd
 ACL.AX :
    * INTENTION TO WITHDRAW TAKEOVER OFFER FOR HEALIUS
    * NO LONGER BELIEVES OFFER CONSIDERATION OF 0.74 ACL SHARES
FOR
EACH HEALIUS SHARE FAIRLY REFLECTS RELATIVE CONTRIBUTION
    * ACL BOARD IS CONCERNED BASED ON 1H GUIDANCE THAT HEALIUS
IS AT
RISK OF A SIGNIFICANT STATUTORY NPAT LOSS IN 1H FY24
    * CONTINUES TO BELIEVE BENEFITS OF A MERGER BETWEEN ACL AND
HEALIUS ARE COMPELLING
    * ALSO NOTES THAT ACCC TODAY ANNOUNCED THAT IT OPPOSES
COMBINATION
OF ACL AND HEALIUS
    * REMAINS OPEN TO A MERGER BETWEEN CO & HEALIUS
    * ACL BOARD INTENDS TO CLOSELY MONITOR PERFORMANCE OF
HEALIUS IN
COMING MONTHS & REMAINS  OPEN TO MERGER BETWEEN  2 COMPANIES
    * CONCERNED BASED ON 1H GUIDANCE THAT HEALIUS IS AT RISK OF
A
SIGNIFICANT STATUTORY NPAT LOSS IN 1H FY24
    * DECISION BY ACCC GIVES CO ABILITY TO CHALLENGE ACCC'S
POSITION
DIRECTLY IN COURT IF IT MAKES A NEW OFFER IN NEAR FUTURE

Source text for Eikon:  ID:nASX12Hg13 
Further company coverage:  ACL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))